PG 116800
PG 116800 (PG 530742) is an orally avtive MMP inhibitor. PG 116800 has high affinity for MMP-2, -3, -8, -9, -13, and -14, while having substantially lower affinity for MMP-1 and -7. PG 116800 can be used for knee osteoarthritis research[1].
Product Specifications
CAS Number
291533-11-4
Product Name Alternative
PG 530742; PGE 530742; PGE 7113313
UNSPSC
12352005
Target
MMP
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/pg-116800.html
Purity
99.81
Solubility
DMSO : 5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
OC(C(NS(=O)(C1=CC=C(NC(C2=CC=C(OC)C=C2)=O)C=C1)=O)CC#CCN3CCOCC3)=O
Molecular Formula
C24H27N3O7S
Molecular Weight
501.55
References & Citations
[1]Piotr Krzeski, et al. Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12-month, double-blind, placebo-controlled study. Arthritis Res Ther. 2007;9 (5) :R109.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
HA723342 100 µL
FAM38B / PIEZO2 Recombinant Rabbit monoclonal Antibody
Sign In for Pricing
View Details 
![PE Anti-Human CD158b/j Antibody[DX27]](https://cdn.genprice.uk/products/763/68dd14a9061270361e7d25ab/imageurl/e-ab-f1381d.webp)